Abbott’s Humira Approved For Juvenile Idiopathic Arthritis
This article was originally published in The Pink Sheet Daily
Executive Summary
Tumor necrosis factor inhibitor an important option to Wyeth’s Enbrel, Abbott tells “The Pink Sheet” DAILY.
You may also be interested in...
Big-Name Drugs Try New Roles In Rheumatism
Lilly’s Cymbalta performs well in major osteoarthritis trial.
Big-Name Drugs Try New Roles In Rheumatism
Lilly’s Cymbalta performs well in major osteoarthritis trial.
Anti-TNFs’ Link To Cancer In Children Under Investigation By FDA
Agency is investigating approximately 30 reports of cancer in pediatric patients.